IV Cocaine Abuse: A Laboratory Model - 4 - Full Text View

IV Cocaine Abuse: A Laboratory Model - 4

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Columbia University
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000215

Purpose

The purpose of this study is to evaluate the effects of pergolide on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Pergolide	Phase II

Drug Information available for:

8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Pergolide Pergolide mesylate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	IV Cocaine Abuse: A Laboratory Model

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Direct cocaine effects (cardio, subjective)
Interaction of cocaine/pergolide on cardio
Interaction of coc/pergolide on coc's subjective
Effects of pergolide on cocaine craving

Estimated Enrollment:	0
Estimated Study Completion Date:	December 2001

Eligibility

Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000215

Locations


United States, New York
	Columbia University
	New York, New York, United States, 10023

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Columbia University

Investigators


Principal Investigator:	Richard Foltin, Ph.D.	Columbia University

More Information

Study ID Numbers:	NIDA-06234-4, R01-06234-4
First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000215
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders

Dopamine

Mental Disorders

Substance-Related Disorders

Disorders of Environmental Origin

Cocaine

Pergolide

Additional relevant MeSH terms:

Neurotransmitter Agents

Molecular Mechanisms of Pharmacological Action

Physiological Effects of Drugs

Dopamine Agents

Dopamine Agonists

Pharmacologic Actions

ClinicalTrials.gov processed this record on December 03, 2008